These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28900828)

  • 1. Everyday life following hematopoietic stem cell transplantation: decline in physical symptoms within the first month and change-related predictors.
    Kroemeke A; Sobczyk-Kruszelnicka M; Kwissa-Gajewska Z
    Qual Life Res; 2018 Jan; 27(1):125-135. PubMed ID: 28900828
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of Life, Physical Functioning, and Psychological Distress of Older Adults Undergoing Hematopoietic Stem Cell Transplantation.
    Newcomb R; Johnson PC; Cronin K; Choe JJ; Holmbeck K; Nabily A; Lark P; Rabideau DJ; DeFilipp Z; Chen YB; El-Jawahri A
    Transplant Cell Ther; 2023 Jun; 29(6):387.e1-387.e7. PubMed ID: 36958693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Factors Influencing Changes in Quality of Life in Patients undergoing Hematopoietic Stem Cell Transplantation: A Longitudinal and Multilevel Analysis].
    Song CE; So HS
    J Korean Acad Nurs; 2015 Oct; 45(5):694-703. PubMed ID: 26582114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of Monitoring Physical Function for Quality of Life Assessments in Hematopoietic Stem Cell Transplantation Patients: A Prospective Cohort Study.
    Kim I; Koh Y; Shin D; Hong J; DO HJ; Kwon SH; Seo KS
    In Vivo; 2020; 34(2):771-777. PubMed ID: 32111783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life trajectories during the first year following hematopoietic cell transplantation: an inception cohort study.
    Devins GM; Mah K; Messner HA; Xenocostas A; Gauvin L; Lipton JH
    Support Care Cancer; 2018 Jul; 26(7):2379-2386. PubMed ID: 29423678
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fear of recurrence and its impact on quality of life in patients with hematological cancers in the course of allogeneic hematopoietic SCT.
    Sarkar S; Scherwath A; Schirmer L; Schulz-Kindermann F; Neumann K; Kruse M; Dinkel A; Kunze S; Balck F; Kröger N; Koch U; Mehnert A
    Bone Marrow Transplant; 2014 Sep; 49(9):1217-22. PubMed ID: 25000458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal Toxicity, Systemic Inflammation, and Liver Biochemistry in Allogeneic Hematopoietic Stem Cell Transplantation.
    Jordan K; Pontoppidan P; Uhlving HH; Kielsen K; Burrin DG; Weischendorff S; Christensen IJ; Jørgensen MH; Heilmann C; Sengeløv H; Müller K
    Biol Blood Marrow Transplant; 2017 Jul; 23(7):1170-1176. PubMed ID: 28344059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.
    Servais S; Baron F; Beguin Y
    Transfus Apher Sci; 2011 Apr; 44(2):205-10. PubMed ID: 21345734
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in Borg scale for resistance training and test of exercise tolerance in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Morishita S; Wakasugi T; Tanaka T; Harada T; Kaida K; Ikegame K; Ogawa H; Domen K
    Support Care Cancer; 2018 Sep; 26(9):3217-3223. PubMed ID: 29626261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sexuality and quality of life of patients with hematologic malignancy and hematopoietic stem cell transplantation: a critical review.
    Tsatsou I; Mystakidou K; Panagou E; Adamakidou T; Kalemikerakis I; Vastardi M; Gkovina O
    J BUON; 2020; 25(4):1693-1706. PubMed ID: 33099903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of outpatient non-myeloablative haematopoietic stem cell transplantation in quality of life vs. conventional therapy.
    Cantú-Rodríguez OG; Sánchez-Cárdenas M; Treviño-Montemayor OR; Gutiérrez-Aguirre CH; Tarín-Arzaga L; Jaime-Pérez JC; Gómez-Almaguer D
    Psychol Health Med; 2016; 21(1):10-9. PubMed ID: 26125120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
    Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?
    Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Kwan J; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Gottlieb D; Kerridge I
    Support Care Cancer; 2017 Feb; 25(2):421-427. PubMed ID: 27699502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT).
    Bevans MF; Mitchell SA; Marden S
    Support Care Cancer; 2008 Nov; 16(11):1243-54. PubMed ID: 18322708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early-phase differences in health-related quality of life, psychological status, and physical function between human leucocyte antigen-haploidentical and other allogeneic haematopoietic stem cell transplantation recipients.
    Morishita S; Kaida K; Yamauchi S; Wakasugi T; Ikegame K; Kodama N; Ogawa H; Domen K
    Eur J Oncol Nurs; 2015 Oct; 19(5):443-50. PubMed ID: 25911269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary treatment of leukemia relapses after allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning second transplantation from the original donor.
    Leung AY; Tse E; Hwang YY; Chan TS; Gill H; Chim CS; Lie AK; Kwong YL
    Am J Hematol; 2013 Jun; 88(6):485-91. PubMed ID: 23512868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic Hematopoietic Stem Cell Transplantation Is an Effective Salvage Therapy for Patients with Chronic Myeloid Leukemia Presenting with Advanced Disease or Failing Treatment with Tyrosine Kinase Inhibitors.
    Nair AP; Barnett MJ; Broady RC; Hogge DE; Song KW; Toze CL; Nantel SH; Power MM; Sutherland HJ; Nevill TJ; Abou Mourad Y; Narayanan S; Gerrie AS; Forrest DL
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1437-44. PubMed ID: 25865648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fatigue and physical activity in patients undergoing hematopoietic stem cell transplant.
    Danaher EH; Ferrans C; Verlen E; Ravandi F; van Besien K; Gelms J; Dieterle N
    Oncol Nurs Forum; 2006 May; 33(3):614-24. PubMed ID: 16676017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells.
    Cieri N; Greco R; Crucitti L; Morelli M; Giglio F; Levati G; Assanelli A; Carrabba MG; Bellio L; Milani R; Lorentino F; Stanghellini MT; De Freitas T; Marktel S; Bernardi M; Corti C; Vago L; Bonini C; Ciceri F; Peccatori J
    Biol Blood Marrow Transplant; 2015 Aug; 21(8):1506-14. PubMed ID: 26001696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.